Skip to main content
. Author manuscript; available in PMC: 2013 Oct 14.
Published in final edited form as: Adv Pharmacol. 2012;65:63–107. doi: 10.1016/B978-0-12-397927-8.00004-X

Table 2.

Clinical Trials*

Drug Clinicaltrials.gov Identifier Site Phase Sponsor
Biomarker Study NCT01130584 Salivary levels of PKM2 Observational National University Hospital, Singapore
TT-232 NCT00422786 Renal Cell Carcinoma II Thallion Pharmaceuticals
TT-232 NCT00735332 Melanoma II Thallion Pharmaceuticals
EZN-2968 NCT00466583 Carcinoma/Lymphoma I Enzon Pharmaceuticals, Inc.
EZN-2968 NCT01120288 Neoplasms/Liver Metastases I National Cancer Institute (Luciani, et al.)
PX-478 NCT00522652 Advanced solid tumors/Lymphoma I Oncothyreon Inc.
AQ4N NCT00394628 Glioblastoma multiforme Ib/IIa Novacea
AQ4N NCT00109356 Lymphoma/Leukemia I/II Novacea
AQ4N NCT00090727 Solid tumors/Non-Hodgkin’s Lymphoma I Novacea
*

Table describes clinical trials mentioned in review. Additional trials can be found at www.clinicaltrials.gov.